Market Tracker

05/27 12:08pm ET

Impax Laboratories Inc (NASDAQ:IPXL)

33.81
BATS BZX Real-Time Price
As of 12:04pm ET
 +0.83 / +2.52%
Today’s Change
27.62
Today|||52-Week Range
51.42
-20.93%
Year-to-Date
No recent news for Impax Laboratories Inc.

Today’s Trading

Previous close32.98
Today’s open33.15
Day’s range33.08 - 33.87
Volume8,632
Average volume (3 months)714,107
Market cap$2.4B
Dividend yield--
Data as of 12:04pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-33.33%
Earnings growth (this year)+17.35%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+44.36%
P/E ratio69.9
Price/Sales3.58
Price/Book2.26

Competitors

 Today’s
change
Today’s
% change
MYGNMyriad Genetics Inc+0.98+2.93%
LGNDLigand Pharmaceutica...-0.11-0.09%
HZNPHorizon Pharma PLC+0.40+2.45%
MDCOMedicines Co+0.52+1.40%
Data as of 12:08pm ET, 05/27/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)$0.42
Annual revenue (last year)$860.5M
Annual profit (last year)$39.0M
Net profit margin4.53%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
George Frederick Wilkinson
Senior Vice President-
Global Operations
Andrew Schaschl
Corporate headquarters
Hayward, California

Forecasts